Knowledge, attitude and practices of Swiss dairy farmers towards intramammary antimicrobial use and antimicrobial resistance : A latent class analysis by Schwendner, Anna Alita et al.
Contents lists available at ScienceDirect
Preventive Veterinary Medicine
journal homepage: www.elsevier.com/locate/prevetmed
Knowledge, attitude and practices of Swiss dairy farmers towards
intramammary antimicrobial use and antimicrobial resistance: A latent class
analysis
Anna-Alita Schwendnera, Theo J.G.M. Lamb,c, Michèle Bodmerd, Marie-Eve Cousine,
Gertraud Schüpbach-Regulaa, Bart H.P. van den Bornea,f,*
a Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Liebefeld, Switzerland
bGD Animal Health, Deventer, the Netherlands
c Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
d Clinic for Ruminants, Vetsuisse Faculty, University of Bern, Bern, Switzerland
e Consumer Behavior, Institute for Environmental Decisions (IED), ETH Zürich, Zürich, Switzerland
f Business Economics Group, Wageningen University, Wageningen, the Netherlands
A R T I C L E I N F O
Keywords:
Clinical mastitis
Subclinical mastitis
Udder health
Mindset
Behaviour
Critically important antimicrobial
A B S T R A C T
Understanding farmers’ mindsets is important to improve antimicrobial stewardship in the dairy industry. This
cross-sectional study aimed to determine farmers’ knowledge, attitude, and practices with respect to lactational
intramammary antimicrobial use (AMU) and antimicrobial resistance (AMR) in Swiss dairy herds. Based on their
approach towards subclinical mastitis (SCM) and non-severe cases of clinical mastitis (CM), subgroups of farmers
were identified and compared regarding their knowledge, attitude and practices towards AMU and AMR. After
conducting qualitative interviews to develop a questionnaire, an online survey was sent to 1296 randomly
selected Swiss dairy farmers. Information was gathered on demographic data and farmers’ knowledge, attitude,
and practices towards AMU and AMR. A latent class analysis was performed to identify subgroups of farmers
based on management of SCM and non-severe CM cases. Based on the results of 542 completed questionnaires,
poor knowledge with respect to AMU and AMR was identified, as well as discrepancies between farmers’ per-
ceptions and their actual practices. Farmers approached cows with SCM and non-severe CM similarly, indicating
they perceived both mastitis states as the same disease. Intramammary antimicrobial products containing cef-
quinome, which is a highest priority critically important antimicrobial, were among the 3 most commonly
applied intramammary antimicrobials. Five latent classes of farmers were identified based on their management
towards SCM and non-severe CM. One group of farmers (18.5% of respondents) indicated that they did not treat
those mastitis cases, one group only treated SCM cases (13.8% of respondents), one group only treated non-
severe CM cases (28.6% of respondents) and the largest group treated both mastitis states (39.1% of re-
spondents). The latter group was subdivided into a latent class of farmers following guidelines for AMU/AMR
(25.5% of respondents) and a group of farmers that were not strictly following these guidelines (13.7% of
respondents). Regional differences between farmers, according to altitude and language region, explained some
of the variation in latent class membership. Latent class membership was associated with farmers’ attitude to use
antimicrobials as little as possible and with using antimicrobials only after performing bacteriological and
susceptibility testing. This study gave detailed insight into Swiss farmers’ knowledge, attitude, and practices
regarding AMU and AMR and provides opportunities to improve antimicrobial stewardship in Swiss dairy herds.
The identified groups of farmers, based on their management practices regarding SCM and non-severe CM, may
help to design tailored intervention strategies for improving prudent AMU in the heterogeneous population of
dairy farmers in Switzerland.
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1. Introduction
Mastitis is the most common reason for administering anti-
microbials to dairy cows (Mitchell et al., 1998; Menéndez González
et al., 2010; Kuipers et al., 2016). Immediate antimicrobial treatment is
advocated for severe clinical mastitis (CM) cases because of an antici-
pated quick recovery and animal welfare aspects. Antimicrobial treat-
ment of subclinical mastitis (SCM) and non-severe CM cases, however,
is not always needed (Lago et al., 2011a, 2011b). Use of intramammary
antimicrobials in dairy cows may contribute to increased antimicrobial
resistance (AMR) of pathogens frequently found in milk (Oliver and
Murinda, 2012; Saini et al., 2012, 2013). Prudent antimicrobial use
(AMU) should therefore be pursued from a precautionary point of view.
Dairy farming in Switzerland is characterized by relatively small
dairy herds with a proportion of, especially the smallest, herds being in
mountainous regions that may not be well serviced by veterinarians
(Gordon et al., 2013). The Swiss dairy population is known for its good
udder health status though, with somatic cell counts being among the
lowest in the world (Gordon et al., 2013). Nevertheless, sales of in-
tramammary antimicrobials seem to be high compared to other Eur-
opean countries (European Medicines Agency, 2017). The herd level
application of blanket dry cow treatment (Gordon et al., 2012) as well
as the incidence rate of CM are relatively low in Switzerland (Gordon
et al., 2013). Antimicrobial use during lactation, on the other hand,
appears to be high (Menéndez González et al., 2010). It is therefore
hypothesized that the high usage of intramammary antimicrobials is
mainly due to the lactational treatment of SCM and non-severe CM.
Although all antimicrobial treatments must be recorded in a treatment
journal on farm, a centralized database on the usage of antimicrobials is
not yet available in Switzerland. Monitoring and benchmarking the
usage of antimicrobials in dairy herds is therefore not possible on a
national scale.
A variety of intramammary antimicrobial products, including pro-
ducts containing beta-lactam antimicrobials, macrolides, lincosamides,
polypeptide antimicrobials and aminoglycosides are registered for
treatment of mastitis in Switzerland. Swiss farmers are allowed to store
most of these products, if they have a written agreement with a ve-
terinarian including two compulsory farm visits per year (Federal Food
Safety and Veterinary Office, 2014), and administer them without ve-
terinary prescription. Third and fourth generation cephalosporins and
macrolides, which are considered as highest priority critically im-
portant (HPCI) for human medicine (World Health Organization,
2017), may be used for mastitis treatment and can also be kept on stock
at the farm.
Several studies have demonstrated the importance of farmers’ atti-
tude towards mastitis and mastitis management and investigated po-
tential intervention and communication strategies towards these sub-
jects. A key strategy is to identify and implement herd-specific measures
to improve udder health in dairy herds (Green et al., 2007; Lam et al.,
2013; Tschopp et al., 2015). Also, farmers have different perceptions of
udder health problems (Jansen et al., 2009) which play an important
role when designing effective intervention programs (Lam et al., 2011).
Attempting to improve udder health may, however, also lead to an
increased number of antimicrobial treatments (Tschopp et al., 2015). A
sustainable udder health program must therefore target a high udder
health status, combined with prudent AMU (van den Borne et al.,
2017). Insights in dairy farmers’ knowledge, attitude and practices to-
wards the lactational use of intramammary antimicrobials is therefore
pivotal to reach this goal. Moreover, the heterogeneous population of
dairy farmers likely has different needs and characteristics. Identifying
subgroups of farmers regarding their practices of intramammary AMU
during lactation may aid to the design of interventions strategies to
enhance prudent AMU in dairy herds.
The aims of this study were to 1) describe farmers’ knowledge, at-
titude, and practices towards the lactational use of intramammary an-
timicrobials in Swiss dairy herds, 2) compare farmers’ mindsets and
management strategies regarding SCM and non-severe CM, 3) identify
groups of farmers based on their practices towards SCM and non-severe
CM, and 4) describe these subgroups of farmers with respect to their
knowledge and attitude regarding AMU and AMR.
2. Materials and methods
The data collection of this study consisted of 2 phases. First, qua-
litative interviews were conducted to determine the range of potential
answers regarding knowledge, attitude and practices of Swiss dairy
farmers towards intramammary AMU during lactation. This informa-
tion was then used to develop the questionnaire for the second phase of
the study in which farmers’ knowledge, attitude and practices were
assessed using a cross-sectional online questionnaire.
2.1. Interviews
An interview protocol was created to facilitate conducting the semi-
structured qualitative interviews among a convenience sample of dairy
farmers. Interviews were initiated with general open-ended questions,
such as “One of your cows has an increased somatic cell count but it doesn’t
show any visible signs of inflammation. What will you do?” Interviewees
were then asked to deliberate freely on this topic. Initial responses were
further investigated by asking farmers more open-ended questions. In-
depth questions, such as “Why do you treat such a cow? With what do you
treat it? And based on which criteria do you apply certain antimicrobials?”
were also asked if not already mentioned. Lastly, farmers were asked
whether there was anything else important to mention at the end of the
interview.
Interviewed farmers had previously participated in another study
(Gordon et al., 2012), and then gave their consent to be approached for
participation in further studies. Farmers were invited to participate by a
letter explaining the purpose of the study. Farmers were subsequently
interviewed, at their own farms, until answers became saturated, which
occurred after interviewing 13 farmers, including 4 interviews with
organic dairy farmers. Interviews were conducted in German, with
farmers from the cantons of Bern, Basel-Country, Solothurn and Aargau
from January to May 2014. The interviews lasted approximately 1 h,
were voice recorded and transcribed in full.
2.2. Questionnaire
The online questionnaire asked for demographic data, knowledge,
attitude and practices of treatment of SCM and non-severe CM cases,
and on AMU and AMR in general. Questions concerning management
decisions when treating SCM and non-severe CM with antimicrobials
could only be answered by those respondents who had applied anti-
microbials to cows with these stages of mastitis during the last 6 months
before the survey. Additionally, the farmers were asked two questions
about their preferred way to acquire knowledge with respect to anti-
microbial stewardship.
To assess which intramammary antimicrobials were commonly used
in Swiss dairy herds, farmers were asked which intramammary anti-
microbial products they (or their veterinarian) had applied during the
last 6 months before the survey. Pictures and product names of all
antimicrobials available for the treatment of mastitis in Switzerland
were presented. Subsequently, farmers were asked to rank the 3 most
frequently used products. Intramammary antimicrobial products were
thereafter grouped based on their active ingredients into HPCI and
other antimicrobials (World Health Organization, 2017). Except for the
ranking, a similar approach was used to quantify which groups of an-
timicrobials farmers had in stock. Based on their treatment records,
farmers were also asked to indicate how many cows they treated for
SCM and non-severe CM in the first 6 months of 2014. Incidence rates of
farmer-reported treated mastitis cases were subsequently calculated
based on the farmer-reported number of treated mastitis cases in the
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first 6 months of 2014, multiplied by two, divided by the herd size,
assuming a constant herd size during the entire year, and multiplied by
100 to express the incidence rate per 100 cow-years at risk.
The questionnaire included a total of 62 questions, of which 38 were
categorical, 7 were quantitative and for 17 a 6-point-Likert-scale was
used. The online survey was developed in German and translated to
French by a professional translator with a background in agriculture.
The questionnaire was pre-tested by 4 farmers who participated in the
qualitative interviews and was adapted according to their feedback. The
questionnaire (in German or French) is available upon request from the
corresponding author. The online survey was conducted using Sawtooth
Software (Orem, Utah, United States of America).
2.3. Target population and sample size estimation
The sampling frame for the online survey consisted of Swiss dairy
farmers who, in May 2014, were regularly marketing milk through a
milk processing company, had a herd size of ≥11 dairy cows and an
email address deposited at the organization responsible for the national
milk quality payment schemes (85% of all Swiss dairy herds in
September 2014; personal communication of TSM Treuhand Ltd., Bern,
Switzerland). Seasonal communal pasture holdings and herds located in
the Italian speaking Canton of Ticino were excluded.
The sample size needed for a cross-sectional study, to estimate a
proportion of 50% from the sampling frame of 20,365 dairy herds with
5% precision and 95% confidence, was calculated to be 385 herds using
Win Episcope 2 software. Given an expected response rate of 30%, 1283
dairy farmers needed to be contacted. Using a stratified (by Swiss
Canton) random sampling approach in Microsoft Excel (Microsoft
Corp., Redmond, Washington, USA), 1296 dairy herds (with stratum
sample sizes proportional to the cantonal dairy herd population) were
eventually requested to participate in the online survey.
2.4. Data collection
According to Swiss legislation, no ethical approval was required for
this study since no sensitive data were collected. Every farmer received
a personalized email explaining the purpose of the study and a link to
the online survey in November 2014. Farmers received reminder emails
2 and 4 weeks later if they had not completed the survey. The survey
was closed in January 2015. To increase response rate, participants
were notified that vouchers of an agricultural wholesaler would be
provided to 110 randomly selected participants who completed the
survey. Additionally, participants were promised a summary of the
project’s results at the end of the study.
2.5. Statistical analysis
Responses were downloaded from the webserver and checked for
consistency and completeness. Incomplete surveys and observations of
4 farmers indicating that they did not own any cows (and were there-
fore assumed to be out of business) were excluded from further ana-
lyses. Counts and proportions were calculated for categorical variables
using frequency and contingency tables. Central measures of tendency
were calculated for continuous variables. Wilcoxon rank sum tests and
χ2-tests were used to determine differences in farmers’ attitude and
practices towards SCM and non-severe CM using NCSS 12 (NCSS, LLC,
Kaysville, Utah, USA). P-values< 0.05 were considered statistically
significant.
Farmers’ actual knowledge regarding AMU and AMR was assessed
using 7 statements with which farmers could agree, with “Yes”, “No”
and “I don’t know” as possible answers. Two statements were reverse-
coded. These were inversed first, after which all responses were binary
coded by merging the incorrect and “I don’t know” answers. The 7
binary coded responses were finally summed into an overall AMU/AMR
knowledge score, on a 0–7 scale.
Latent class analysis, a useful method to analyse latent relationships
between observed categorical variables (Oberski, 2016), was performed
to identify subgroups of farmers managing SCM and non-severe CM.
This helps to understand how the latent classes’ characteristics differ
from each other. Ten categorical questionnaire items describing
farmers’ practices towards SCM and non-severe CM were included in a
complete-case exploratory latent class analysis. A series of latent class
models with increasing number of classes, from 2 to 7, was performed
to determine the best fitting model. The model with the lowest Bayesian
information criterion (BIC), adjusted-BIC (aBIC), and Akaike informa-
tion criterion (AIC), and a high entropy, was selected (Nylund et al.,
2007). The selected model was repeatedly estimated using increasing
random start values until the log likelihood was replicated several times
to assure a final model solution (Nylund et al., 2007). Thirteen demo-
graphic covariates were added to this latent class analysis model one at
a time using univariable multinomial logistic regression models to
identify predictors explaining latent class membership. Covariates
having a P<0.15 in the likelihood-ratio test were subsequently offered
to a backward multivariable model selection procedure until all cov-
ariates were significantly (P<0.05) contributing to the final model.
Confounding was evaluated and defined as a change in model estimates
of more than 20% when removing a covariate from the model. A
variable was retained in the model if confounding was present. For the
final statistical model, item response probabilities were computed and
interpreted to describe the classes. Posterior probabilities for each
farmer being in each latent class were computed and the class with the
highest posterior probability was assigned to each respondent. Latent
class analysis was conducted using PROC LCA 1.3.2 (Lanza et al., 2007)
in SAS 9.4 (SAS Institute Inc, Cary, North Carolina, USA).
Relationships between latent class membership and 10 attitude
items, and both subjective and objective knowledge on AMU and AMR
were assessed using a Kruskal-Wallis one-way ANOVA on ranks. A
Bonferroni adjustment (P<0.004) was applied to correct for multiple
comparisons. Differences between classes were assessed by the post
hoc, multiple comparison Dwass, Steel, Critchlow-Fligner procedure in
PROC NPAR1WAY in SAS 9.4 (SAS Institute Inc, Cary, North Carolina,
USA).
3. Results
3.1. Demographic composition
Of 1296 farmers contacted, 542 (41.8%) completed the survey of
which 478 (out of 1085; response rate: 44.1%) and 64 (out of 211;
response rate 30.3%) were filled in by German and French-speaking
farmers, respectively. Many farms (40.2%; n = 218; 95%-CI:
36.2–44.4%) were in lowland regions; 19.2% (n = 104; 95%-CI:
16.1–22.7%) in areas with hills and 40.1% (n = 220; 95%-CI:
36.5–44.8%) in mountainous regions. Free-stall housing systems were
used in 37.8% (n = 205; 95%-CI: 33.8–42.0%) of farms, 47.4% (n =
257; 95%-CI: 43.2–51.6%) had a tie-stall housing system, with the re-
maining farms having both types of housing systems. For 95.2% (n =
516; 95%-CI: 93.1–96.7%) of farmers, dairy farming was their main
source of income. Additional production types were crop farming
(47.8%; n = 259; 95%-CI: 43.6–52.0%) and other livestock species
(29.7%; n = 161; 95%-CI: 26.0–33.7%). Most famers produced under
the “Integrierte Produktion (IP Suisse)” label program (76.9%; n =
417; 95%-CI: 73.2–80.3%), a program that promotes a sustainable and
integrative farming by focusing on animal- and environmental-friendly
farming activities, including the promotion of biodiversity, animal
welfare, the reduction of greenhouse gasses, and the avoidance of
pesticides. Conventional production (10.0%; n = 54; 95%-CI:
7.7–12.8%), organic farming (11.6%; n = 63; 95%-CI: 9.2–14.6%) and
other production systems (1.5%; n = 8; 95%-CI: 0.7–2.9%) were also
represented. Median farmer-reported herd size was 24 dairy cows
(range 6–150) and farmers’ age ranged from 23 to 70 years (median 48
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years). Most respondents had a certificate of competence (43.5%; n =
236; 95%-CI: 39.4–47.7%) or had completed a professional degree
(29.9%; n = 162; 95%-CI: 26.2–33.9%), which are both federally ap-
proved agricultural degrees. Other farmers (26.6%; n = 144; 95%-CI:
23.0–30.4%) had completed a higher agricultural education.
3.2. Management decisions regarding SCM and non-severe CM
In 60.9% of the herds (n = 328; 95%-CI: 56.3–64.5%), one or more
cows received treatment for non-severe CM in the first 6 months of
2014. Significantly more farmers had treated a cow for non-severe CM
than they had treated a cow for SCM in the first 6 months of 2014
(47.4%; n = 256; 95%-CI: 43.1–51.4%; P<0.0001). In herds in which
cows were treated, median farmer-reported incidence rate was 16.0 per
100 cow-years at risk (mean = 20.2; range 2.5–133.3) for treated non-
severe CM cases and 14.3 (mean 19.6; range 2.2–108.7) for treated
SCM. Distributions of farmer-reported incidence rates of treated SCM
and non-severe CM cases in all 542 herds are shown in Fig. 1. Con-
sidering all herds (and thus including herds that did not treat SCM or
non-severe CM), median farmer-reported incidence rate was 8.9 per
100 cow-years at risk (mean = 13.1; range 0–240.0) for treated non-
severe CM cases and 0 (mean = 9.6; range 0–160.0) for treated SCM
cases during lactation.
Categorical management decisions regarding cows with SCM or
non-severe CM are shown in Table 1. The most important reason for a
farmer to call a veterinarian for an antimicrobial treatment of a case of
mastitis differed between SCM and non-severe CM (P = 0.005). A first
unsuccessful treatment was often mentioned as the most important
reason (SCM: 26.2% (95%-CI: 20.4–33.0%); non-severe CM: 33.8%
(95%-CI: 28.5–39.6%)). Increased somatic cell counts (SCM: 32.2%
(95%-CI: 25.9–39.3%); non-severe CM: 26.6% (95%-CI: 21.8–32.1%))
or a positive Californian Mastitis Test (SCM: 19.7% (95%-CI:
14.6–26.0%)) were also frequently mentioned. In herds that treated
SCM or non-severe CM with antimicrobials, additional costs was a de-
cisive factor for not calling a veterinarian to initiate treatment, but this
did not differ between SCM and non-severe CM (P = 0.49; Table 1).
More than 60% of the farmers indicated that milk samples for bacter-
iological testing were taken by themselves or their veterinarian before
initiation of treatment. This proportion was slightly higher for non-se-
vere CM cases than for SCM cases whereas the proportion of farmers not
taking a milk sample for bacteriological testing was higher for SCM (P
= 0.02). The most important reason for farmers to not take a milk
sample for bacteriological testing before antimicrobial treatment was
that they experienced that treatment of SCM (46.3; 95%-CI:
37.2–55.7%) and non-severe CM (45.4%; 95%-CI: 37.1–54.0%) is also
successful without. Routinely collecting a milk sample post-treatment
to evaluate bacteriological cure was not frequently done (SCM: 7.4%
(95%-CI: 3.8–13.9%); non-severe CM: 6.2% (95%-CI: 3.2–11.7%)).
When treating SCM or non-severe CM, approximately half of the herds
(63.8% for SCM, 51.5% for non-severe CM) had less than 5% of SCM
and non-severe CM cases treated by a veterinarian (Fig. 2).
Table 2 shows that most factors influencing management decisions
(on a 6-point Likert scale) regarding intramammary treatment were not
different for SCM or non-severe CM. Age (mean: 3.1 SCM; 2.8 non-
severe CM) and pregnancy status of the cow (mean: 4.0 SCM; 3.6 non-
severe CM), however, were considered more important for treatment
decisions of SCM than of non-severe CM. Farmers indicated that the
result of a bacteriological test and the recommendations of their ve-
terinarian were the most important factors in their decision-making
processes. Costs and having antimicrobials in stock were considered less
important. Antimicrobial treatment was ceased based on the veter-
inarian’s recommendations or the farmer’s own judgment (Table 2).
Poor prognosis and the cow’s pregnancy status were indicated as im-
portant decisive factors regarding culling of cows with SCM or non-
severe CM.
Intramammary antimicrobial products containing a combination of
neomycin and procaine-penicillin, a combination of gentamicin and
procaine-penicillin, and cefquinome were the 3 most frequently used
intramammary antimicrobials in Switzerland (Appendix 1). Of the HPCI
antimicrobials, cefquinome was mentioned most frequently as first
choice.
3.3. Knowledge about AMU and AMR
Distributions of answers to the 7 statements making up the AMU/
AMR knowledge score are presented in Fig. 3. Farmers knew that
bacteria vary in their susceptibility to different antimicrobials but
59.8% (n = 318; 95%-CI: 55.6–63.8%) did not know what an anti-
microbial susceptibility test was. Most respondents (79.0%; n = 428;
95%-CI: 75.3–82.2%) also did not know that HPCI antimicrobials are
used for the treatment of mastitis. For 58.5% (n = 317; 95%-CI:
54.3–62.6%) of farmers, antimicrobial resistance means that bacteria
are not susceptible to antimicrobials. By means of another statement,
76.9% (n = 417; 95%-CI: 73.2–80.3%) answered that it was synon-
ymous for them with an unsuccessful treatment. The fact that anti-
microbial resistance may emerge from the incorrect application of an-
timicrobials (86.9%; n = 471; 95%-CI: 83.8–89.5%) and that
antimicrobial resistance in veterinary medicine poses a potential risk to
public health (63.7%; n = 345; 95%-CI: 59.5–67.6%) was clear to most
farmers. In addition to these 7 statements, most farmers (86.0%; n =
466; 95%-CI: 82.8–88.7%) knew that antimicrobials are meant to treat
bacteria. Some, however, thought that antimicrobials can also be used
to treat viruses (28.6%; n = 155; 95%-CI: 25.0–32.5%), fungi (16.8%; n
= 91; 95%-CI: 13.9–20.2%), and parasites (16.1%; n = 87; 95%-CI:
13.2–19.4%). Thirteen farmers (2.4%; 95%-CI: 1.4–4.0%) also filled in
the “other” option, in which “inflammations” (n = 7) was mostly
commonly stated.
Farmers’ agreed only moderately (mean = 3.8; SD = 1.1) with the
perceived knowledge statement “I have the opinion that I have sufficient
knowledge about antimicrobials and the development of antimicrobial re-
sistance”. Although the mean AMU/AMR knowledge score (mean= 3.7;
SD = 1.4; range 0–7) was similar to the mean perceived knowledge
score, their correlation was low (Spearman rank correlation coefficient
= 0.11; P<0.007).
3.4. Attitude towards AMU and AMR
Table 3 shows the respondents’ attitudes towards AMU and AMR.
Most farmers had the opinion that antimicrobials are emergency drugs
and should only be used after consulting a veterinarian (mean = 5.0).
Most farmers indicated to use antimicrobials as little as possible (mean
= 5.3), partly to save costs (mean = 3.7). Farmers also agreed with the
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Fig. 1. Histogram of farmer-reported incidence rate (cases per 100 cow-years at
risk) of treated subclinical mastitis (light grey) and non-severe clinical mastitis
(dark grey) in 542 Swiss dairy farms in 2014.
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statement that antimicrobials should only be used after performing an
antimicrobial susceptibility test (mean = 4.2). They thought it is very
important to adhere to the duration of therapy as indicated by the ve-
terinarian (mean = 5.4) or the package leaflet (mean = 5.1). Most
farmers think it is the duty of the veterinarian to mention to the
herdsmen that they suspect an udder health problem in the herd (mean
= 4.3). It was found that most farmers thought that there is a problem
with AMR (mean = 4.1), but they only moderately agreed with the
statement that usage of antimicrobials is too high in Swiss dairy farms
(mean = 3.4).
3.5. AMU and AMR practices
An antimicrobial susceptibility test was requested in all mastitis
cases by 18.3% (n = 99; 95%-CI: 15.2–21.7%) of farmers while 42.6%
(n = 231; 95%-CI: 38.5–46.8%) of farmers let their veterinarian decide,
22.9% (n = 124; 95%-CI: 19.5–26.6%) never requested a test and
16.2% (n = 88; 95%-CI: 13.3–19.6%) did that sometimes. For 80.3% of
farmers (n = 435, 95%-CI: 76.7–83.4%) their veterinarian provided a
treatment protocol. For 22.5% (n = 122; 95%-CI: 19.2–26.2%) of
farmers, the protocol was provided in a written form, whereas for
57.8% (n = 313; 95%-CI: 53.6–61.8%) of farmers it was communicated
orally. Half (51.5%; n = 279; 95%-CI: 47.2–55.7%) of the dairy farmers
indicated that they did not store any antimicrobials on their farm;
12.7% (n = 69; 95%-CI: 10.1–15.8%) stored HPCI intramammary an-
timicrobials while 35.8% (n = 194; 31.9–39.9%) stored non-HPCI in-
tramammary antimicrobials only.
3.6. Latent class membership
The latent class analysis model with 5 latent classes had the lowest
AIC, BIC and aBIC and a high entropy and was therefore selected as the
final model (Appendix 2). This final model, presented in Table 4,
identified a group of farmers that did not treat SCM and non-severe CM
in the 6 months preceding the start of the survey (latent class 1; n =
100; 18.5%; 95%-CI: 15.4–21.9%), a group that only treated SCM cases
(latent class 2; n = 75; 13.8%; 95%-CI: 11.1–17.0%), a group that only
Table 1
Management decisions of Swiss dairy farmers towards treatment of non-severe clinical mastitis and subclinical mastitis in 2014 – categorical variables. For all
questions, only a single answer could be provided.
Non-severe clinical mastitis Subclinical mastitis P-value1
N % N %
“What is the most important factor for you to call your veterinarian for a visit related to a cow with mastitis” (278)2 (183) 0.005
Economic value of the cow 18 6.5 13 7.1
Positive result of Californian Mastitis Test 25 9.0 36 19.7
Increased somatic cell count 74 26.6 59 32.2
Reduced milk yield 12 4.3 3 1.6
Clinical signs 34 12.2 13 7.1
Previous own treatment was unsuccessful 94 33.8 48 26.2
Other reasons 21 7.6 11 6.0
“What is the most important factor for you to not call your veterinarian for a visit related to a cow with
mastitis?”
(334) (258) 0.487
Additional costs 191 57.2 130 50.4
Additional workload for me when the veterinarian is coming 2 0.6 2 0.8
It takes longer before cow receives treatment 40 12.0 39 15.1
Other reasons 101 30.2 87 33.7
“Do you, or your veterinarian, take a milk sample for bacteriological testing before treating a cow with
mastitis?”
(367) (287) 0.024
Yes 237 64.6 179 62.4
No 19 5.2 31 10.8
Sometimes 111 30.3 77 26.8
“What is the most important reason for you to not take a milk sample for bacteriological testing before treating
a cow with mastitis?”
(130) (108) 0.655
It is too expensive 9 6.9 7 6.5
It takes too long before laboratory results arrive 38 29.2 37 34.3
I have good experiences without 59 45.4 50 46.3
My veterinarian hasn’t explained the benefits of a milk sample to me 0 0.0 2 1.9
Other reasons 24 18.5 12 11.1
“Do you, or your veterinarian, take a milk sample after treating a cow with mastitis to evaluate bacteriological
cure?”
(130) (108) 0.631
Yes 8 6.2 8 7.4
No 85 65.4 75 69.4
Sometimes 37 28.5 25 23.2
1 Based on the χ2 test.
2 Total number of respondents for this questionnaire item.
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Fig. 2. Histogram of farmer-reported percentage of intramammary anti-
microbial treatments performed by a veterinarian for subclinical mastitis (light
grey; n = 287) and non-severe clinical mastitis (dark grey; n = 367) in Swiss
dairy farms.
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treated non-severe CM cases (latent class 3; n = 155; 28.6%; 95%-CI:
24.0–32.5%), and a larger group of farmers that treated both mastitis
states. The latter group was subdivided into a group of farmers who
were following guidelines for prudent AMU (latent class 4; n = 138;
25.5%; 95%-CI: 22.0–29.3%) and into those who do not strictly follow
these guidelines (latent class 5; n = 74; 13.7%; 95%-CI: 11.0–16.8%).
Latent class 1 was not only characterized by not treating SCM or non-
severe CM but also had the lowest probability for storing any anti-
microbials on farm. Latent class 2 (only treating SCM cases) and 3 (only
treating non-severe CM) were characterized by a moderate probability
of taking a milk sample before treatment initiation. In both latent
classes, in 63% of the SCM and non-severe CM cases a milk sample was
Table 2
Management decisions of Swiss dairy farmers towards non-severe clinical mastitis and subclinical mastitis in 2014 – ordinal variables. For all questions, farmers had
to indicate for each option whether they agreed with it. Statements were rated on a Likert scale from 1 (fully disagree) to 6 (fully agree).
Non-severe clinical mastitis Subclinical mastitis P-value1
Mean SD Mean SD
“How decisive are the following criteria for you to use intramammary antimicrobials when treating a cow with
mastitis?”
(356)2 (272)
Additional medical costs 2.5 1.3 2.7 1.4 0.17
Length of the milk withdrawal period 3.0 1.4 3.0 1.4 0.92
Age of the cow 2.8 1.5 3.1 1.4 0.01
Milk yield 3.6 1.5 3.7 1.4 0.36
Pregnancy status 3.6 1.6 4.0 1.5 0.004
Availability of replacement heifers 3.0 1.5 3.2 1.4 0.12
Recommendations by the veterinarian 4.4 1.3 4.6 1.1 0.35
Positive bacteriological status of milk sample 4.8 1.2 4.9 1.0 0.34
Lactation stage 3.7 1.4 3.8 1.4 0.41
Previously unsuccessful treatments 3.9 1.6 3.9 1.7 0.73
On-farm availability of antimicrobials 2.0 1.3 2.0 1.2 0.63
“I cease treatment with antimicrobials …” (356) (272)
… when somatic cell counts are normal again 3.9 1.6 4.1 1.5 0.13
… when the Californian Mastitis Test gives a negative result 4.1 1.5 4.1 1.5 0.46
… according to the recommendations in the package leaflet 3.9 1.7 3.9 1.6 0.97
… according to the recommendations of my veterinarian 4.9 1.2 5.0 1.0 0.42
… if I consider a case to be cured 4.2 1.5 4.2 1.5 0.91
“How decisive are the following criteria for you to cull a cow with mastitis?” (347) (255)
Additional costs 3.5 1.4 3.3 1.5 0.20
Poor prognosis 5.1 1.0 5.1 0.9 0.27
Availability of replacement heifers 3.7 1.5 3.6 1.4 0.27
Age of the cow 4.1 1.3 4.0 1.3 0.49
Milk yield 4.3 1.2 4.3 1.3 0.96
Lactation stage 3.9 1.3 3.9 1.4 0.60
Pregnancy status 5.1 1.1 5.0 1.2 0.22
1 Based on the Wilcoxon rank sum test.
2 Total number of respondents for this questionnaire item.
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taken for bacteriological testing. Latent class 4 (treating both mastitis
states – following guidelines for AMU/AMR) was characterized as
having a high probability of systematically taking a milk sample before
treatment initiation (88% in case of SCM and 97% in case of non-severe
CM). Latent class 5 (treating both mastitis states – not strictly following
guidelines for AMU/AMR) less frequently took a milk sample before
treatment initiation and had the highest probability for storing anti-
microbials on farm, including the HPCI antimicrobials. This group also
had the lowest probability for having a treatment protocol and the
highest probability for not requesting an antimicrobial susceptibility
test when submitting a milk sample for laboratory testing.
Two covariates explained latent class membership in the final
multinomial logistic regression model (Table 5). Relative to farmers
from mountainous regions, farmers from lowland regions had higher
odds for belonging to latent class 3 (only treating non-severe CM; OR =
2.2), latent class 4 (treating both mastitis states – following guidelines
for AMU/AMR; OR = 3.2) and latent class 5 (treating both mastitis
states – not strictly following guidelines for AMU/AMR; OR = 4.1).
Farmers from hilly regions also had 2.6 times higher odds for latent
class 4 membership (treating both mastitis states – following guidelines
for AMU/AMR) than farmers from mountainous regions. Farmers from
the French-speaking region of Switzerland had 4 times higher odds to
belong to latent class 5 (treating both mastitis states – not strictly fol-
lowing guidelines for AMU/AMR) compared to German-speaking
farmers.
Latent class membership was associated with farmers’ knowledge
and attitude (Table 6). Members of latent class 4 (treating both mastitis
states – following guidelines for AMU/AMR) less strongly tried “to use
antimicrobials as little as possible” compared with latent class 2 (only
treating SCM) and 3 (only treating non-severe CM) members. Re-
spondents grouped in latent class 2 (only treating SCM) and 4 (treating
both mastitis states – following guidelines for AMU/AMR) agreed more
strongly with “using antimicrobials only after taking a milk sample and
performing a susceptibility test” than latent class 5 respondents (treating
both mastitis states – not strictly following guidelines for AMU/AMR).
There were no differences between the 5 latent classes concerning
farmers’ subjective and objective knowledge or any of the other attitude
items included in the analysis.
4. Discussion
This study scrutinized farmers’ knowledge, attitude and practices
regarding the use of intramammary antimicrobials in Swiss dairy herds
and determined subgroups of farmers regarding their lactational
treatment practices towards SCM and non-severe CM. Within the rela-
tively large group of farmers that treated both mastitis states in the last
6 months before conducting the survey, there was a subgroup that
complied with guidelines for antimicrobial stewardship (latent class 4)
and a smaller group that was less compliant (latent class 5). Besides a
reduction in the use of antimicrobials (by treating less SCM or non-
severe CM cases), there is potential for improving prudent AMU in
latent class 5 (treating both mastitis states – not strictly following
guidelines for AMU/AMR) whereas farmers belonging to latent class 4
were already following guidelines for AMU/AMR. The identification of
the heterogeneity of farmers regarding their approach towards treating
SCM and non-severe CM cases is an important observation because la-
tent class membership was associated with several aspects of farmers’
attitude towards AMU/AMR. Although identified relationships cannot
be considered causal given the cross-sectional design of the survey and
the fact that bias may occur by conducting a questionnaire study, this
study identified areas that may be targeted to improve prudent AMU in
subgroups of farmers. Other studies need to confirm whether subgroups
of farmers can also be observed in other countries.
Knowledge, attitude, and practices did not differ much between
subgroups of farmers. Therefore, a generic approach is needed also to
change the mindset of the entire dairy farmer population. This does not
only include educating farmers on different aspects of AMU/AMR, but
also implementing regulations, setting new social norms, and providing
farmers with tools helping them to optimize AMU and AMR (Lam et al.,
2017). Options for social norm change include, amongst others, mass-
media strategies, facilitating public debate, publicly awarding good
examples, and setting benchmarks and reference points (Young, 2015;
Lam et al., 2017). Examples of tools to optimize AMU/AMR practices
include herd-specific treatment protocols and a central database re-
gistering on-farm usage of antimicrobials to allow monitoring and
benchmarking. Such a system, which will be based on prescription data
of veterinarians, has become operational in Switzerland in 2019. A
coordinated approach, as is preferred by Swiss dairy farmers and ve-
terinarians (van den Borne et al., 2017), including these different ap-
proaches is expected to result in improved antimicrobial stewardship.
Regional and language differences were both observed between
latent classes. Herds located in mountainous regions were more fre-
quently owned by farmers not treating SCM or non-severe CM cases
than herds in hilly or lowland regions. Farms located in Swiss moun-
tainous regions are often smaller and less professional than herds lo-
cated at lower altitude (Gordon et al., 2012). Smaller herds may have
had no non-severe CM or SCM cases, simply because they are smaller,
but herd size was not associated with latent class membership in the
statistical analysis. Farmers with herds at higher altitude may lack the
confidence to initiate an antimicrobial treatment, since they experience
less mastitis cases, or they may consider it too costly for a veterinarian
to visit the herd because they are less accessible. These farmers may
therefore decide that cases of non-severe CM or SCM do not need
treatment at all. The difference in latent class membership between the
French- and German-speaking regions may be caused by the various
milk quality requirements in different regions of Switzerland. A sig-
nificant proportion of the milk in the French-speaking region of Swit-
zerland is processed into raw milk cheese, which has more strict milk
quality requirements compared to the requirements in the German-
speaking region where milk is generally pasteurized. Farmers in the
French-speaking part of the country may thus be more under pressure
to treat SCM and non-severe CM cases with antimicrobials to meet these
Table 3
Description of statements regarding the attitude of 542 Swiss dairy farmers towards antimicrobial use and antimicrobial resistance in 2014.
Mean SD
“I think there is a nation-wide problem with antimicrobial resistance regarding mastitis pathogens” 4.1 1.3
“I think the usage of intramammary antimicrobials is too high in Swiss farms” 3.4 1.3
“For me it is important to adhere to the therapy duration indicated in the package insert” 5.1 1.0
“For me it is important to adhere to the therapy duration as instructed by my veterinarian” 5.4 0.8
“For me, antimicrobials are medications which can be routinely used without consulting a veterinarian” 1.9 1.2
“For me, antimicrobials are emergency medications and should only be used for a targeted therapy and after consulting a veterinarian.” 5.0 1.2
“I try to use antimicrobials as little as possible” 5.3 0.9
“To keep costs low, I use antimicrobials as little as possible” 3.7 1.6
“Antimicrobials should only be used after taking a milk sample and conducting a susceptibility test” 4.2 1.3
“It is the duty of the veterinarian to talk to me when he/she assumes an udder health problem in my herd” 4.3 1.4
Statements were rated on a Likert scale from 1 (fully disagree) to 6 (fully agree).
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requirements. Whether or not stricter milk quality requirements lead to
higher usage of antimicrobials remains speculation and needs further
study.
Both farmers’ perceived knowledge and their actually tested
knowledge on AMU/AMR was moderate. Farmers were aware of certain
aspects of AMU/AMR but were lacking knowledge on other relevant
aspects, including the fact that HPCI antimicrobials were used to treat
mastitis. Farmers’ knowledge on AMU and AMR may improve through
national communication and education campaigns and discussions with
their veterinarians (Higham et al., 2018). The use of HPCI anti-
microbials for instance, is assumed to become substantially lower if it is
given attention through regulations and education on potential public
health effects (Lam et al., 2017).
Most farmers indicated to use antimicrobials as little as possible,
partly in order to reduce costs (Jones et al., 2015). This, however,
conflicts with the high sales of intramammary antimicrobials in Swit-
zerland (European Medicines Agency, 2017). Additionally, farmers only
moderately agreed with the statement that intramammary AMU was
too high in Swiss dairy herds. This indicates that there may be a mis-
conception between perceived and actual intramammary AMU, espe-
cially when placed in an international perspective. Treatment decisions
of farmers are influenced by the societal context they are in (Vaarst
et al., 2007; Jansen and Lam, 2012) which likely is also true for Swiss
dairy farmers. Swiss dairy farmers generally receive a bonus when their
bulk milk somatic cell counts is< 100,000 cells/mL. Given the low
average herd size and the large effect of an individual cow, farmers may
treat cows during lactation to reduce somatic cell count levels to obtain
a financial bonus on their bulk milk result, with high AMU as a result.
Incorporating AMU as an additional criterion for receiving a financial
bonus is expected to result in an additional reduction in AMU (van den
Borne et al., 2017). Also, the initiation of a national database to monitor
and benchmark the usage of antimicrobials will facilitate national and
international comparisons and will showcase the high usage of in-
tramammary antimicrobials during lactation. This can be a starting
point for a discussion on decreasing the usage of antimicrobials in Swiss
dairy herds.
Most farmers in the current study had the opinion that there is a
nation-wide problem with AMR of mastitis pathogens and stated that
AMR is the unsuccessful treatment of an animal, rather than the ability
of antimicrobials to kill or inhibit bacteria. However, resistance levels
of antimicrobials commonly used to treat major mastitis pathogens in
Switzerland are generally below 10% (Corti et al., 2003; Moser et al.,
2013a; Overesch et al., 2013) with only penicillin resistance in Sta-
phylococcus aureus and resistance levels in non-aureus staphylococci
being higher (Frey et al., 2013; Moser et al., 2013b; Overesch et al.,
2013). Antimicrobial resistance is only one possible explanation for
treatment failure (Barkema et al., 2006; van den Borne et al., 2010) and
incorrectly interpreting AMR as treatment failure may therefore explain
the discrepancy between farmers’ perceived and actual AMR levels of
mastitis pathogens.
Bacteriological identification and susceptibility testing are con-
sidered cornerstones of prudent AMU (Prescott, 2008; Oliver et al.,
2011; Teale and Moulin, 2012). More than sixty percent of farmers in
the current study reported to always take a milk sample before treating
a cow with antimicrobials. This percentage is high compared to the
Netherlands for instance (Griffioen et al., 2016), but similar to ob-
servations from Scandinavia (Vakkamäki et al., 2017; Emanuelson
et al., 2018), and is promising from a prudent AMU perspective. On the
other hand, farmers often have difficulties interpreting results from
bacteriological tests (Jansen et al., 2010). It is therefore likely that in
Switzerland, where farmers generally have small herds and little ex-
perience with laboratory results, that veterinarians are consulted in
many cases before initiation of treatment. Susceptibility testing was not
routinely requested by farmers and over 40% of farmers let their ve-
terinarian decide whether to perform a susceptibility test. Together
with the observation that most farmers consider it a responsibility of
veterinarians to address assumed udder health problems with farmers,
this opens opportunities for veterinarians to support their clients and to
discuss AMU. This study reemphasized the importance of veterinary
practitioners on farmers’ antimicrobial stewardship (Friedman et al.,
2007; Jones et al., 2015; Higham et al., 2018) and that there is room for
improvement regarding the communication between farmers and ve-
terinarians (Lam et al., 2011; Pothmann et al., 2013; Tschopp et al.,
2015).
Antimicrobial treatment initiation has previously been described to
differ between severe and non-severe CM cases (Vaarst et al., 2002;
Jones et al., 2015). In our current study, we found that, although the
majority (80%) of farmers in our study differentiated between SCM and
non-severe CM, treatment decisions of both mastitis states were similar.
This discrepancy between the diagnosis and management approach
may be explained by the fact that farmers see SCM and non-severe CM
as different stages of the same disease (Vaarst et al., 2002).
This study focused on the lactational treatment of non-severe CM
and SCM mainly. Farmers’ knowledge, attitude, and practices regarding
severe CM and dry cow treatment were not assessed given the length of
the questionnaire and the indications for a high usage of intramammary
antimicrobials during lactation in Swiss dairy herds (Menéndez
González et al., 2010; European Medicines Agency, 2017). No conclu-
sions on the mindset of farmers regarding the treatment of severe CM or
at dry-off can therefore be drawn from this study. Furthermore, the
number of treated mastitis cases, rather than the number of disease
cases, was surveyed when determining incidence rates. This was done
because focus was on farmers’ mindset regarding AMU/AMR, not on
their mindset regarding udder health. This, however, may complicate
making comparisons with incidence rate estimates from other studies.
The overall response rate (42%) was in between the response rates
of two previously conducted questionnaires in the same target popu-
lation of Swiss dairy herds (47% and 37%, respectively; Gordon et al.,
2012; van den Borne et al., 2017) and therefore as expected. Re-
markably, a difference in response rate was observed between the
Table 5
Covariates associated with Swiss dairy farmers’ (n = 542) latent class membership regarding antimicrobial use and antimicrobial resistance (AMU/AMR) in the final
multivariable multinomial logistic regression model.
Lowland vs mountainous regions Hilly vs mountainous regions French vs German speaking
Latent Class Odds Ratio Odds Ratio Odds Ratio
5. Treats both – not strictly following guidelines for AMU/AMR 4.1 (2.0–8.4) 1.3 (0.5–3.5) 3.9 (1.5–9.8)
4. Treats both – following guidelines for AMU/AMR 3.2 (1.7–5.9) 2.6 (1.3–5.3) 1.9 (0.8–4.5)
3. Treats non-severe CM1 2.2 (1.2–3.9) 1.4 (0.7–2.7) 1.2 (0.5–3.0)
2. Treats SCM2 1.1 (0.6–2.3) 0.7 (0.3–1.6)
7.%2 (0.2–2.3)
1. Does not treat Reference Reference Reference
95%-confidence intervals are presented between brackets.
1 Clinical mastitis.
2 Subclinical mastitis.
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German- (44%) and French-speaking farmers (30%) though. There are
cultural differences between the two regions, which potentially could
explain this observation, but a difference in response rate was not ob-
served before (Gordon et al., 2012). French-speaking farmers, however,
were more likely to belong to latent class 5 (treating both mastitis states
– not strictly following guidelines for AMU/AMR) compared to German-
speaking farmers. It may thus be possible that farmers from the French-
speaking region were less willing to participate in this survey con-
cerning a highly societal sensitive topic. The results of this ques-
tionnaire should therefore be interpreted in light of this potential re-
sponse bias.
Most farmers treated both SCM and non-severe CM before calling
their veterinarian for a visit. Additional costs were stated to be a de-
cisive factor for this, which was also described earlier (Raymond et al.,
2006; Friedman et al., 2007). Factors, such as animal welfare and good
stockman ship may, however, also play a role (Espetvedt et al., 2013).
The fact that antimicrobial treatment is mostly initiated by farmers
without the support of evidence-based guidelines or a prescription of a
veterinarian may pose a risk for a suboptimal intramammary AMU.
Practices conflicting with a prudent antimicrobial use are, for instance,
when farmers use antimicrobials off-label or without applying a bac-
teriological test. Antimicrobials may be used more judiciously when
prescribed by veterinarians. Farmers find written treatment protocols
helpful in reducing errors when treating intramammary infections
(Raymond et al., 2006; Jones et al., 2015) but only 22% of farmers had
such a protocol in the current study. Promoting the use of written
treatment protocols is assumed to further improve antimicrobial stew-
ardship (Oliver et al., 2011) and to bring conformity among treatment
practices in Swiss dairy herds.
As in other countries (Higham et al., 2018), cefquinome, one of the
HPCI antimicrobials (World Health Organization, 2017), was com-
monly used to treat mastitis in Switzerland. Comparable to other
countries (Mevius and Heederik, 2014), the Swiss authorities
implemented a stricter legislation that prohibits keeping HPCI anti-
microbials in stock on the farm. Usage of HPCI is therefore expected to
decrease.
5. Conclusions
This study identified subgroups of farmers with respect to the
treatment of SCM and non-severe CM which were associated with some
attitude questionnaire items. This allows a targeted approach to sub-
groups of farmers when developing strategies to improve prudent in-
tramammary AMU in Switzerland. Swiss farmers lacked knowledge on
certain items of AMU and AMR, including the usage of HPCI anti-
microbials for the treatment of mastitis. The relatively high use of di-
agnostics to identify IMI gives opportunities for veterinarians to provide
more services to farmers and discuss options to improve antimicrobial
stewardship in Swiss dairy herds. This study provides important in-
sights into farmers’ mindsets towards AMU/AMR. Its results can be used
to develop strategies to reduce, replace and refine intramammary an-
timicrobial usage in dairy herds.
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Appendix 1 Application of intramammary antimicrobials in Swiss dairy herds for the treatment of non-severe clinical and subclinical
mastitis in 2014
Antimicrobials Mastitis Ranked 1 Ranked 2 Ranked 3 Not ranked (> 3) P -value1
N % N % N % N %
Ampicillin, cloxacillin Non-severe 22 6.5 18 7.4 14 9.0 11 6.0 0.36
Subclinical 13 5.6 12 7.8 6 8.8 2 4.2
Amoxicillin, clavulanic acid Non-severe 26 7.7 16 6.6 20 12.9 19 10.3 0.03
Subclinical 18 7.7 14 9.2 9 13.2 1 2.1
Cloxacillin, colistin Non-severe 29 8.6 35 14.5 7 4.5 15 8.2 0.76
Subclinical 15 6.4 13 8.5 7 10.3 3 6.3
Cefquinome2 Non-severe 41 12.1 25 10.3 12 7.7 13 7.1 0.20
Subclinical 28 12.0 21 13.7 6 8.8 3 6.3
Cefoperazone2 Non-severe 10 3.0 15 6.2 8 5.2 12 6.5 0.32
Subclinical 6 2.6 11 7.2 4 5.9 2 4.2
Cefalexin Non-severe 2 0.6 1 0.4 2 1.3 2 1.1 (-)
Subclinical 2 0.9 0 0.0 2 2.9 0 0.0
Cefalixin, kanamycin Non-severe 5 1.5 11 4.5 15 9.7 9 4.9 0.07
Subclinical 6 2.6 10 6.5 3 4.4 4 8.3
Cefapirin Non-severe 5 1.5 2 0.8 0 0.0 4 2.2 (-)
Subclinical 4 1.7 3 2.0 0 0.0 0 0.0
Dihydrostreptomycin, nafcillin, procaine penicillin Non-severe 12 3.6 4 1.7 3 1.9 9 4.9 1.00
Subclinical 6 2.6 6 3.9 2 2.9 0 0.0
Gentamicin, procaine penicillin Non-severe 74 21.9 38 15.7 18 11.6 10 5.4 0.62
Subclinical 47 20.2 20 13.1 6 8.8 6 12.5
Kanamycin, spiramycin2 Non-severe 6 1.8 22 9.1 23 14.8 17 9.2 0.06
Subclinical 8 3.4 13 8.5 5 7.4 6 12.5
Lincomycin, neomycin Non-severe 12 3.6 6 2.5 9 5.8 8 4.3 0.40
Subclinical 6 2.6 5 3.3 3 4.4 2 4.2
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Neomycin, procaine penicillin Non-severe 76 22.5 33 13.6 12 7.7 12 6.5 0.25
Subclinical 56 24.0 16 10.5 6 8.8 4 8.3
Procaine penicillin Non-severe 16 4.7 12 5.0 7 4.5 37 20.1 0.23
Subclinical 16 6.9 5 3.3 5 7.4 15 31.3
Spiramycin2 Non-severe 2 0.6 4 1.7 5 3.2 6 3.3 (-)
Subclinical 2 0.9 4 2.6 4 5.9 0 0.0
Total responses Non-severe 338 100.0 242 100 155 100 184 100
Subclinical 233 100.0 153 100 68 100 48 100
Farmers were asked which intramammary antimicrobial products they applied when treating subclinical and non-severe clinical mastitis. They
subsequently created a ranking of the 3 most frequently applied.
1 Based on the χ2 test.
2 Antimicrobials critically important for human medicine with highest priority (World Health Organization, 2017).
Appendix 2 Fit statistics of different subscale latent class analysis models
Classes AIC BIC aBIC Entropy
2 2862.9 3056.2 2913.3 1.0
3 2107.8 2399.8 2184.0 1.0
4 1456.2 1847.1 1558.2 1.0
5 1346.8 1836.4 1474.6 0.98
6 1382.3 1970.7 1535.8 0.98
7 1392.1 2079.3 1571.4 0.93
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